Karen Malone | CEO
GeneScape
Karen is a biomarkers and genetics expert. With years of drug development experience, having worked previously at Janssen Pharmaceuticals and other innovative biotechs, she is dedicated to developing new tools to tackle challenges in the rare disease space.
Appearances:
Day 1 - Wednesday 23 October @ 14:10
Showcase 1: Uncovering genetically defined patients for improved diagnosis, drug development and commercial strategy
Session led by:
Day 1 - Wednesday 23 October @ 14:10
Showcase 1: Uncovering genetically defined patients for improved diagnosis, drug development and commercial strategy
Session led by:
last published: 11/Oct/24 14:35 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events